Evaluation and Management of Abnormal Complete Blood Cell Count Results
Introduction to Abnormal CBC Results
- Leukopenia may indicate bone marrow failure, infection, or immune-mediated destruction requiring prompt evaluation 1
- The presence of immature cells or blasts in peripheral blood requires immediate bone marrow evaluation as this may indicate leukemia 2, 3
- Abnormal WBC differential percentages may indicate specific disease processes including infection, inflammation, or malignancy 1
- Severe thrombocytopenia increases bleeding risk and may require immediate intervention 1
Diagnostic Approach
- For new or worsening cytopenias, repeat CBC testing should be performed within 2-4 weeks 2, 3
- If abnormalities persist or worsen over two or more measurements, bone marrow aspiration/biopsy with cytogenetics should be performed 2, 3
- The American Society of Clinical Oncology recommends consideration of bone marrow evaluation for persistent unexplained cytopenias 5
- The American College of Rheumatology suggests that patients on medications that can affect blood counts require regular monitoring 6
Special Considerations
- Patients with known predisposition to hematologic malignancies require more frequent monitoring (every 3-4 months) 5
- Patients receiving methotrexate should have CBC, liver function tests, and renal function monitored within 1-2 months of starting therapy and every 3-4 months thereafter 6
- The National Comprehensive Cancer Network recommends that patients on biologic therapies should have baseline CBC with differential and periodic monitoring during treatment 7
- The College of American Pathologists suggests that pre-analytical variables that can affect results should be considered 8